BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15652749)

  • 1. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
    Baldassarre G; Belletti B; Nicoloso MS; Schiappacassi M; Vecchione A; Spessotto P; Morrione A; Canzonieri V; Colombatti A
    Cancer Cell; 2005 Jan; 7(1):51-63. PubMed ID: 15652749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27(Kip1) and stathmin share the stage for the first time.
    Iancu-Rubin C; Atweh GF
    Trends Cell Biol; 2005 Jul; 15(7):346-8. PubMed ID: 15951178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing roles for p21(waf1/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration.
    Stehr W; Mercer TI; Bernal NP; Erwin CR; Warner BW
    Surgery; 2005 Aug; 138(2):187-94. PubMed ID: 16153426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit.
    Cunningham JJ; Levine EM; Zindy F; Goloubeva O; Roussel MF; Smeyne RJ
    Mol Cell Neurosci; 2002 Mar; 19(3):359-74. PubMed ID: 11906209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
    Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
    J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.
    Uchida T; Nakamura T; Hashimoto N; Matsuda T; Kotani K; Sakaue H; Kido Y; Hayashi Y; Nakayama KI; White MF; Kasuga M
    Nat Med; 2005 Feb; 11(2):175-82. PubMed ID: 15685168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 induction of cellular migration requires p27(KIP1).
    Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
    Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.
    Philipp-Staheli J; Payne SR; Kemp CJ
    Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.
    Fabris L; Berton S; Pellizzari I; Segatto I; D'Andrea S; Armenia J; Bomben R; Schiappacassi M; Gattei V; Philips MR; Vecchione A; Belletti B; Baldassarre G
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13916-21. PubMed ID: 26512117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland.
    Deans AJ; Simpson KJ; Trivett MK; Brown MA; McArthur GA
    Oncogene; 2004 Aug; 23(36):6136-45. PubMed ID: 15208652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation.
    Larocque D; Galarneau A; Liu HN; Scott M; Almazan G; Richard S
    Nat Neurosci; 2005 Jan; 8(1):27-33. PubMed ID: 15568022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and subcellular localization of the microtubule-destabilizing stathmin family phosphoproteins in cortical neurons.
    Gavet O; El Messari S; Ozon S; Sobel A
    J Neurosci Res; 2002 Jun; 68(5):535-50. PubMed ID: 12111843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin.
    Ng DC; Lin BH; Lim CP; Huang G; Zhang T; Poli V; Cao X
    J Cell Biol; 2006 Jan; 172(2):245-57. PubMed ID: 16401721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.
    Belletti B; Pellizzari I; Berton S; Fabris L; Wolf K; Lovat F; Schiappacassi M; D'Andrea S; Nicoloso MS; Lovisa S; Sonego M; Defilippi P; Vecchione A; Colombatti A; Friedl P; Baldassarre G
    Mol Cell Biol; 2010 May; 30(9):2229-40. PubMed ID: 20194624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
    Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
    Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.